While most people with Type 2 diabetes would like to see a cure in the near future, there are still many new treatment approaches on the horizon. Many new treatments focus on comorbidities, such as obesity.
Another diabetes drug, dapagliflozin, may soon be available to treat type 2 diabetes. Dapagliflozin is the first in a new class of diabetes drugs called the "SGLT2 inhibitors" (or, if you prefer, the sodium-glucose transporter-2 inhibitors), which work by a novel mechanism of action: they cause extra loss of glucose into the urine. Here's the…